Mike Sathekge

8.1k total citations · 1 hit paper
280 papers, 5.1k citations indexed

About

Mike Sathekge is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mike Sathekge has authored 280 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Radiology, Nuclear Medicine and Imaging, 92 papers in Pulmonary and Respiratory Medicine and 77 papers in Oncology. Recurrent topics in Mike Sathekge's work include Radiopharmaceutical Chemistry and Applications (91 papers), Medical Imaging Techniques and Applications (56 papers) and Prostate Cancer Treatment and Research (55 papers). Mike Sathekge is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (91 papers), Medical Imaging Techniques and Applications (56 papers) and Prostate Cancer Treatment and Research (55 papers). Mike Sathekge collaborates with scholars based in South Africa, Belgium and United States. Mike Sathekge's co-authors include Mariza Vorster, Alex Maes, Ismaheel O. Lawal, Christophe Van de Wiele, Thomas Ebenhan, Thabo Lengana, Frank Bruchertseifer, Aliyah Morgenstern, Alfred O. Ankrah and Jan Rijn Zeevaart and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mike Sathekge

262 papers receiving 5.0k citations

Hit Papers

An Overview of Targeted Alpha Therapy with 225Actinium an... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers

Mike Sathekge
Mary T. Keogan United States
Mathew L. Thakur United States
Rodney A. Schmidt United States
Hongming Zhuang United States
Mike Sathekge
Citations per year, relative to Mike Sathekge Mike Sathekge (= 1×) peers Andor W.J.M. Glaudemans

Countries citing papers authored by Mike Sathekge

Since Specialization
Citations

This map shows the geographic impact of Mike Sathekge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Sathekge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Sathekge more than expected).

Fields of papers citing papers by Mike Sathekge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Sathekge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Sathekge. The network helps show where Mike Sathekge may publish in the future.

Co-authorship network of co-authors of Mike Sathekge

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Sathekge. A scholar is included among the top collaborators of Mike Sathekge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Sathekge. Mike Sathekge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seifert, Robert, George Prenosil, Mike Sathekge, et al.. (2025). Optimizing theranostics chatbots with context-augmented large language models. Theranostics. 15(12). 5693–5704. 1 indexed citations
2.
Mokoala, Kgomotso, et al.. (2025). The implication of aberrant NRF2 activation in management of female cancers. Frontiers in Oncology. 15. 1579135–1579135.
3.
Palestro, Christopher J., Gad Abikhzer, Zvi Bar‐Sever, et al.. (2024). Summary: Appropriate Use Criteria for the Use of Nuclear Medicine in Fever of Unknown Origin. Journal of Nuclear Medicine. 65(11). 1786–1788.
4.
Baxi, Siddhartha, Angela Hong, Nicola Mulholland, et al.. (2024). Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study. Journal of Nuclear Medicine. 65(9). 1450–1455. 2 indexed citations
5.
Loy, Tom Van, Mike Sathekge, Christophe M. Deroose, et al.. (2024). Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging. Nuclear Medicine and Biology. 132-133. 108906–108906. 3 indexed citations
6.
Abikhzer, Gad, Giorgio Treglia, Matthieu Pelletier‐Galarneau, et al.. (2024). EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 510–538. 22 indexed citations
7.
Sathekge, Mike, et al.. (2023). Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease. SHILAP Revista de lepidopterología. 3. 1224905–1224905. 1 indexed citations
8.
Aldous, C, et al.. (2023). Emerging theragnostic radionuclide applications for hepatocellular carcinoma. SHILAP Revista de lepidopterología. 3. 1210982–1210982. 2 indexed citations
9.
Guo, Hua, Yanping Yang, Haluk Sayman, et al.. (2023). 89Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations. EJNMMI Radiopharmacy and Chemistry. 8(1). 36–36. 2 indexed citations
10.
Kruger, Hendrik G., Mike Sathekge, Jan Rijn Zeevaart, et al.. (2022). Using Antibiotics Scaffolds Will Warrant Novel Radiotracers for Effective Positron Emission Tomography Imaging of Infections: Triumph or Pitfall?. 36–36. 1 indexed citations
11.
Mokoala, Kgomotso, Ismaheel O. Lawal, Honest Ndlovu, et al.. (2022). A Prospective Investigation of Tumor Hypoxia Imaging with 68Ga-Nitroimidazole PET/CT in Patients with Carcinoma of the Cervix Uteri and Comparison with 18F-FDG PET/CT: Correlation with Immunohistochemistry. Journal of Clinical Medicine. 11(4). 962–962. 7 indexed citations
12.
Lawal, Ismaheel O., et al.. (2022). Molecular Imaging of Tuberculosis. Seminars in Nuclear Medicine. 53(1). 37–56. 13 indexed citations
13.
Lawal, Ismaheel O., Thabo Lengana, Gbenga O. Popoola, et al.. (2021). Pattern of Prostate Cancer Recurrence Assessed by 68Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy. Journal of Clinical Medicine. 10(17). 3883–3883. 10 indexed citations
14.
Signore, Alberto, Vera Artiko, Guillermina Ferro‐Flores, et al.. (2020). Imaging Bacteria with Radiolabelled Probes: Is It Feasible?. Journal of Clinical Medicine. 9(8). 2372–2372. 28 indexed citations
15.
Lawal, Ismaheel O., Anton Stoltz, & Mike Sathekge. (2020). Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection. Clinical and Translational Imaging. 8(3). 141–155. 4 indexed citations
16.
Sathekge, Mike, Frank Bruchertseifer, Otto Knoesen, et al.. (2019). 225Ac-PSMA-617 in Chemotherapy-naive Patients with Advanced Prostate Cancer. Journal of medical imaging and radiation sciences. 50(1). S30–S30. 1 indexed citations
17.
18.
Morice‐Picard, Fanny, Hamid Rezvani, Frédéric Austerlitz, et al.. (2019). Xeroderma pigmentosum in South Africa: Evidence for a prevalent founder effect. British Journal of Dermatology. 181(5). 1070–1072. 9 indexed citations
19.
Ebenhan, Thomas, R. Suhas, Thavendran Govender, et al.. (2015). Synthesis,68Ga-Radiolabeling, and PreliminaryIn VivoAssessment of a Depsipeptide-Derived Compound as a Potential PET/CT Infection Imaging Agent. BioMed Research International. 2015. 1–12. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026